Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 5, 2003, Pages 1148-1150

  Croak, Andrew ^a   Abate, George ^a   Goodrum, Kenneth ^a   Modrzakowski, Malcolm ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Antibiotic; Group B Streptococcus; Resistance; Sensitivity; Serotype V

Indexed keywords

AMPICILLIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; HUMAN; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; SPECIES DISTRIBUTION; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

EID: 0038734174     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.293     Document Type: Article

References (7)

1. Rouse DJ, Andrews WW, Lin FY, Mott CW, Ware JC, Philips JB 3rd. Antibiotic susceptibility profile of group B streptococcus acquired vertically. Obstet Gynecol 1998;92:931-4.
2. Murdoch DR, Reller LB. Antimicrobial susceptibilities of group B streptococci isolated in patients with invasive disease: 10 year perspective. Antimicrob Agents Chemother 2001;45:3623-4.
3. Bland ML, Vermillion ST, Soper DE, Austin M. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol 2001;184:1125-6.
4. Paoletti LJ, Bradford J, Paoletti LC. A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts. J Clin Microbiol 1999;37:3759-60.
5. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999;104:203-9.
6. Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996;173:365-73.
7. Harrison LH, Elliott JA, Dwyer DM, Libonati JP, Ferrieri P, Billmann L, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 1998;177:998-1002.